Bimatoprost

This page contains recent news articles, when available, and an overview of Bimatoprost but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

Bat your eyes: Latisse prescription enhances eyelashes  -  ‎Dec 23, 2009‎
Many products claim to improve eyelash thickness and appearance, but Latisse Allergan (bimatoprost ophthalmic solution) 0.03 percent is the first and only ... The Ann Arbor News - MLive.com

To Latisse, Even Brooke Shields' Eylashes Are “Not Enoughâ€?  -  ‎Jan 4, 2010‎
Consumer Reports explains that Latisse's active ingredient, bimatoprost, “has been known to darken even blue and green eyes to a permanent dark brown. ... Washington City Paper (blog)

The Make-A-Wish Foundation(R) Receives $1 Million Donation from LATISSE(R ...  -  ‎Dec 17, 2009‎
The most common side effects after using LATISSE® (bimatoprost ophthalmic solution) 0.03% are an itching sensation in the eyes and/or eye redness. PR Newswire (press release)

Top Five Greenwash Posts of the Year  -  ‎Dec 22, 2009‎
Spokeswoman Brooke Shields wants to tell you about the miracle anti-aging cure: bimatoprost ophthalmic solution. Oh, if that's a too hard to pronounce, ... Triple Pundit

雷射刺激毛囊 「拂髮ã€?無邊ä¸?是夢  -  ‎Dec 31, 2009‎
...å?¦ä¸€æ–¹é?¢ï¼Œåœ¨æ²»ç™‚çš„å?Œæ™‚,加上外用刺激毛髮生長的治療劑(例如Minoxidil生髮水ã€?Bimatoprostã€?富å?«è¡€å°?æ?¿è¡€æ¼¿PRP等),å?¯ä½¿é ­çš®ä¸Šï¼Œç¶“雷射製造的顯微加熱å?€åŠ é€Ÿé€™äº› ... 自由時報

Lashing out at Latisse®  -  ‎Nov 3, 2009‎
Bimatoprost (Lumigan®) and latanoprost (Xalatan®) are members of the prostamide class of drugs that can manage some forms of glaucoma by reducing ... ScienceBlogs (blog)

Latisse®: Tell me more about my eyes  -  ‎Nov 4, 2009‎
Lookie what came in to my e-mail box overnight after yesterday's post about the hypotrichosis treatment, Latisse® brand of bimatoprost. Hmm.. ... ScienceBlogs (blog)

Lumigan X EU Committee Recomendation  -  ‎Oct 28, 2009‎
...of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). ... Gerson Lehrman Group

Allergan Reports Third Quarter 2009 Operating Results  -  ‎Oct 29, 2009‎
On July 14, 2009, Allergan announced Korea Food and Drug Administration (KFDA) approval of LATISSE (bimatoprost ophthalmic solution) 0.03%, ... Reuters

EU committee backs marketing approval of Lumigan  -  ‎Oct 24, 2009‎
...granting a Marketing Authorisation for a new version of Lumigan (bimatoprost ophthalmic solution) 0.01% in the 27 member states of the European Union. ... pharmabiz.com

CHMP issues latest recommendations, OK for Movetis' Resolor  -  ‎Oct 26, 2009‎
...of Pfizer's erectile dysfunction blockbuster Viagra (sildenafil) and a new formulation of Allergan's Lumigan (bimatoprost) for glaucoma patients. ... Pharma Times

The Mane Event  -  ‎Nov 9, 2009‎
Allergan's Latisse, containing the prostaglandin analog bimatoprost, recently made history by becoming the first FDA-approved medication for eyelash growth. ... Allentown Morning Call

Allergan to file NDA for Bimatoprost for stimulatinmg eyelash growth  -  Jun 4, 2008
LONDON (Thomson Financial) - Allergan Inc. said it intends to file a New Drug Application by end of the third quarter of 2008 with the US Food and Drug ... Forbes

FDA Seizes Cosmetic That Can Blind  -  Nov 19, 2007
At fault is a compound called bimatoprost, approved by the FDA for use in treating people with certain eye problems, but unapproved as a casual cosmetic. ... Wired News

Bimatoprost/timolol fixed combination vs latanoprost/timolol fixed …  -  Jun 6, 2008
Correspondence: A Martínez, Instituto Gallego de Oftalmología, C/Ramón Baltar Sn, Santiago de Compostela, La Coruña 15706, Spain. Tel: +34 646 17 81 04; ... Nature.com

A 6-month assessment of bimatoprost 0.03% vs timolol maleate 0.5%: …  -  Oct 28, 2005
Correspondence: Dr JG Feijoo, Hospital Clinico San Carlos, Martin Lagos sn, 28040 Madrid, Spain. Tel: +349 1330 3977; Fax: +349 1330 3961; ... Nature.com

Allergan drug lengthens eyelashes -US FDA staff  -  Dec 3, 2008
The analysis was prepared for a Food and Drug Administration advisory panel that meets Friday to evaluate the proposed cosmetic use of the drug, bimatoprost ... Reuters

US seizes discontinued eyelash product  -  Nov 17, 2007
The product contains bimatoprost, an active ingredient in an FDA-approved drug to treat this condition. For patients on the prescription drug, ... Reuters UK

… h IOP control with latanoprost, travoprost, and bimatoprost in...  -  Mar 17, 2006
This clinical study received no financial support from any public or private organization. No author had any proprietary interest in the products mentioned ... Nature.com

Allergan Eye Drop Gets Clearance  -  Jun 23, 2006
Earlier, Lumigan -- bimatoprost ophthalmic solution 0.03% -- had received approval in 2001 as a pressure-lowering medication for second-line use. ... TheStreet.com - TheStreet.com (subscription)

… Recommends Approval of LATISSEâ„¢ (Bimatoprost Solution 0.03%) as a ...  -  Dec 5, 2008
...to recommend that the FDA approve LATISSEâ„¢ (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes. ... International Business Times

FDA seizes eyelash growth product containing bimatoprost  -  Nov 26, 2007
The US Food and Drug Administration recently seized $2 million in applicator tubes of Age Intervention Eyelash, which may cause vision loss, according to a ... OSN SuperSite

Jeepers Peepers!  -  Feb 24, 2008
Some of the products contained small amounts of bimatoprost, ... Apparently, bimatoprost stimulates lash growth; opthalmologists who prescribed it for ... New York Times

Bimatoprost (Ophthalmic).  -  Jul 28, 2005
Bimatoprost(By-Matoh-prohst) is used to treat certain diseases of the eye like glaucoma which occurs in many people as they grow older. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

Bimatoprost (Ophthalmic).(Drug overview)  -  May 1, 2006
Bimatoprost(By-Matoh-prohst) is used to treat certain diseases of the eye like glaucoma which occurs in many people as they grow older. ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com

… Reduction of Intraocular Pressure Between Bimatoprost and Travoprost...  -  Oct 20, 2005
Two-thirds of those receiving bimatoprost had open-angle glaucoma (OAG) and ... Mean reduction of IOP after 3 months was 7.8 mm Hg in the bimatoprost group ... DG News

… Recommends Approval of Allergan's (AGN) LATISSE(TM) (Bimatoprost …  -  Dec 8, 2008
...recommend that the FDA approve LATISSE(TM) (bimatoprost solution 0.03%) as a treatment for hypotrichosis (or reduced amount of hair) of the eyelashes. ... StreetInsider.com - StreetInsider.com (subscription)

Comparing Bimatoprost Daily versus Every Two Days in Patients With …  -  May 15, 2007
By Earl R. Nichols. FORT LAUDERDALE, FL -- May 15, 2007 -- Much of the problem with hyperemia, burning and itching associated with use of ocular bimatoprost ... DG News

Bimatoprost as effective as travoprost in blacks.(News Review)(Brief ...  -  Nov 15, 2005
Four years ago, research revealed that Travatan (travoprost, Alcon) was more effective in lowering intraocular pressure in blacks than in whites. (1) ... Free with registration - Review of Optometry - AccessMyLibrary.com

Drug company creates eyelash thickener  -  Jun 5, 2008
A clinical trial showed that bimatoprost -- a synthetic prostaglandin analog -- results ... If approved by the FDA, Allergan's bimatoprost product would be ... United Press International

Athena withdraws its eyelash enhancer  -  Nov 21, 2007
Athena has decided to stop selling Revitalash as it contains bimatoprost, ... The company cites 'possible public concern over bimatoprost' as the reason ... CosmeticsDesign.com

… .(NEW PRODUCTS)(Allergan bimatoprost ophthalmic solution approval)(...  -  Aug 1, 2006
The FDA has approved bimatoprost ophthalmic solution 0.03% (Lumigan), manufactured by Irvine, California-based Allergan, Inc. The once-daily eye drop, ... Free with registration - Long-Term Care Interface - AccessMyLibrary.com

BRIEFLY Mild weather to go on until October Most of the country will ...  -  Aug 5, 2005
From September 1 Pharmac will remove the ``special authority'' from glaucoma eye drops bimatoprost, latanoprost and travoprost, and prescribing will instead ... Pay-Per-View - New Zealand Herald - Factiva, from Dow Jones

… Intent to File New Drug Application for Bimatoprost as Novel...  -  Apr 6, 2008
..."Our exploration of bimatoprost as an eyelash growth enhancer reflects our ... Allergan has exclusive US and foreign patents on the use of bimatoprost and ... Ad-Hoc-News - Ad-Hoc-News (Pressemitteilung)

Allergan Receives Pan European License for GANFORT(R) (LUMIGAN(R …  -  May 25, 2006
A fixed combination of bimatoprost 0.03% and timolol maleate 0.5%, GANFORT(R) offers powerful IOP-lowering efficacy comparable to the free combination of ... Free with registration - Business Wire - AccessMyLibrary.com

… comparable with a single drop of bimatoprost, travoprost, study...  -  Apr 24, 2008
Single drops of bimatoprost and travoprost appear to provide comparable ... Mean IOP at baseline was 20.6 mm Hg in the bimatoprost group and 21.1 mm Hg in ... OSN SuperSite

The Fight Is On for Drug That Lengthens Eyelashes  -  Nov 19, 2007
LUMIGAN® (bimatoprost ophthalmic solution) 0.03% has been reported to cause changes to pigmented tissues. The most frequently reported changes have been ... Medgadget.com

Bimatoprost shows better efficacy, similar tolerability to timolol...  -  Feb 6, 2008
Administering bimatoprost once daily appears more effective for lowering IOP compared with twice-daily timolol in patients with chronic angle-closure ... OSN SuperSite

bimatoprost + timolol Allergan registered, EU (glaucoma).  -  Jun 5, 2006
On 25 May 2006 Allergan announced that the European Commission has granted marketing authorization for GANFORT in the EU for the treatment of glaucoma. ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones

SJ COMPANY WILL TAKE 2 COSMETICS OFF SHELVES - FDA, PATENT …  -  Jan 8, 2008
The federal agency said the product was made with bimatoprost, which in some people might cause swelling of the retina and inflammation in the eye, ... $2.95 - San Jose Mercury News - NewsBank

Akorn, Inc. Signs Exclusive Definitive Agreement For the Development ...  -  Jan 9, 2007
Switzerland, to develop and supply Latanoprost, Bimatoprost and Travoprost, three ophthalmic ANDA drug products for the treatment of glaucoma. ... Genetic Engineering News - Genetic Engineering News (press release)

FDA: RevitaLash Can Cause Redness, Irritation  -  Dec 10, 2007
Health officials said it contained bimatoprost, an active ingredient in a drug used to treat an eye disease. FDA officials said they're currently also ... WBAL TV

Study: Bimatoprost does not induce macular changes in glaucoma …  -  Aug 28, 2008
A study by researchers in South Korea has found that applying topical bimatoprost to the phakic eyes of glaucoma patients is effective for reducing IOP ... OSN SuperSite

Bimatoprost/Timolol Fixed Combination Therapy Demonstrates …  -  Jun 3, 2008
Greater intra-ocular pressure (IOP) lowering benefit can be achieved for glaucoma patients treated with a fixed combination of bimatoprost and timolol ... Medical News Today - Medical News Today (press release)

Adherence to glaucoma therapy of vital importance: rate of patient …  -  Feb 1, 2005
The mean numbers of days that patients remained taking latanoprost, travoprost, and bimatoprost were 281, 287, and 291, respectively. ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

Orange County Business Journal Online  -  Jul 18, 2008
Allergan said it completed a clinical trial that showed bimatoprost, ... The company estimates that global peak sales for bimatoprost for eyelash growth ... Orange County Business Journal - Orange County Business Journal

Press Release: New Head to Head Data(1) Show Efficacy of Treatment …  -  Dec 11, 2007
The European Glaucoma Society (EGS) guidelines outline that bimatoprost ... A fixed combination of bimatoprost 0.03% and timolol maleate 0.5%, GANFORT ... ... Pay-Per-View - PR Newswire Europe - HighBeam Research

A drug for longer lashes?  -  Jun 10, 2008
The company has now reformulated bimatoprost to be applied directly to the base of the ... Bimatoprost is a synthetic member of the prostaglandin family, ... Chemistry World

The clinical validity of the treatment satisfaction survey for...  -  Jun 3, 2005
Sherwood M, Brandt J, Bimatoprost Study Groups 1 and 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients ... Nature.com

Prostaglandin analogues.(Cosmeceutical Critique)  -  Jul 1, 2007
Bimatoprost is a topical ocular hypotensive lipid therapy, formulated as ... They concluded that such effects present sooner with bimatoprost than with ... $4.95 - Skin & Allergy News - ECNext

Press Release: Bimatoprost / Timolol Fixed Combination Therapy …  -  Jun 2, 2008
Bimatoprost / Timolol Fixed Combination Therapy Demonstrates Significantly Better IOP Control Over 12 Hours Compared to Latanoprost / Timolol Combination. Pay-Per-View - PR Newswire Europe - HighBeam Research

Video: Allergan Announces US Food and Drug Administration (FDA) …  -  Dec 26, 2008
Patients treated with bimatoprost for this specific eye condition ... The long-term safety of bimatoprost for therapeutic use has been recognized by the ... RedOrbit

Iperpigmentazione periorbitale indotta da Bimatoprost  -  Feb 3, 2006
Venerdì 03 Febbraio 2006 - Sono stati esaminati i cambiamenti dell'iperpigmentazione cutanea indotta dal farmaco anti-glaucoma Bimatoprost ( Lumigan ). ... XagenaSalute

Britânicas usam remédio contra glaucoma para aumentar cílios  -  Nov 27, 2007
...já teria levado a uma corrida entre as indústrias farmacêuticas pelo desenvolvimento de tratamentos cosméticos usando o seu ingrediente, bimatoprost. ... Estadão

Aprobada por la UE la combinación de bimatoprost y timolol para el …  -  May 30, 2006
Una combinación de bimatoprost y timolol para tratar el glaucoma acaba de ser aprobada por la autoridades sanitarias de la Unión Europea. ... Intramed.net - Intramed.net (Suscripción)

Optimal outcomes using adjunctive therapy in glaucoma management.( …  -  Aug 15, 2007
In 2003, Parrish and coworkers showed that latanoprost, bimatoprost, ... MUNDORF: In the Lumigan (bimatoprost) Early Experience Data (LEED) study, ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

Longer Lashes in a Tube? Maybe Not  -  Jul 3, 2008
Concurrently, Allergan, which sells bimatoprost as an antiglaucoma drug called ... The makers of these four products say they don't contain bimatoprost. ... New York Times

Identification and pharmacological characterization of the prostagland...  -  Apr 21, 2008
Background and purpose: A prostamide analogue, bimatoprost, ... In contrast, bimatoprost elicited an immediate increase in intracellular Ca 2+ followed by a ... Nature.com

NO.1 경제í?¬í„¸ :: 매ì?¼ê²½ì œ  -  Jun 5, 2008
...보톡스로 유명한 앨러간 제약회사가 개발한 비마토프로스트(bimatoprost)�는 � 약 � 합성프로스타글란딘 유사물질로 �미 임�시험� 완료했으며 곧 �품�약국(FDA) ... 매�경제

International Approvals: Takepron, Ganfort, Kaletra  -  Jul 5, 2006
On May 25, the European Commission approved bimatoprost/timolol 0.03%0.5% ophthalmic solution ( Ganfort [ Lumigan/timolol], made by Allergan, ... Medscape

¿Pueden crecer las pestañas?  -  Jun 6, 2008
Se trata del bimatoprost, que usualmente se usa contra el glaucoma, una seria afección ocular. Al parecer, observaron que las personas tratadas con ese ... Clarín.com

دواء جديد لتحÙ?يز رموش العينين على النمو  -  Jun 5, 2008
إنها طورت علاجاً تجميلياً باستخدام دواء bimatoprost من أجل تحÙ?يز رموش العينين على النمو. ... العرب اونلاين

Press Release: Video: Allergan Announces US Food and Drug …  -  Dec 26, 2008
Patients treated with bimatoprost for this specific eye condition ... The long-term safety of bimatoprost for therapeutic use has been recognized by the ... Pay-Per-View - PR Newswire - HighBeam Research

Explaining benefits enhances acceptance of therapy: adherence to 10P-...  -  Sep 1, 2007
The proportion of patients willing to continue to use bimatoprost remained high in the intervention group throughout the study (range, 91.7% to 98.1%), ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

… LA COMBINACIÓN FIJA BIMATOPROST / TIMOLOL DEMUESTRA UN …  -  Jun 2, 2008
Berlín, Alemania.- Se puede lograr el beneficio de una gran disminución de la presión intraocular (IOP, por sus siglas en inglés) en pacientes con glaucoma ... acceso.com

Novo Cosmético Pode Prejudicar a Visão  -  Oct 4, 2008
...“Quanto menor for a concentração de bimatoprost neste cosmético, menores serão ... Cuidados no uso - Queiroz Neto ressalta que se o bimatoprost penetrar na ... Revista Fator

:: Novo Cosmético Pode Prejudicar a Visão  -  Oct 14, 2008
...“Quanto menor for a concentração de bimatoprost neste cosmético, menores serão ... Queiroz Neto ressalta que se o bimatoprost penetrar na corrente sanguínea ... Tribuna - A Tribuna

美 엘러간 ì†?눈ì?¹ 발모제 승ì?¸  -  Dec 30, 2008
...미국�서 엘러간(Allergan)� �눈� 발모제� '�티쎄'(Latisse, bimatoprost) 0.03% 가 승�� 얻었다. FDA는 �티쎄를 �눈� 빈모�� 대한 처방 치료제로 승�했다 ... 디지틀보사

Fixed combination glaucoma medications await US approvals  -  Nov 1, 2005
The bimatoprost-timolol combination from Allergan received an approvable letter ... Allergan, maker of Combigan and the fixed combination of bimatoprost and ... OSN SuperSite

Fabricante de Botox planea ahora elongar las pestañas - Nicaragua Hoy  -  Jun 4, 2008
Allergan finalizó las pruebas clínicas de un medicamento llamado bimatoprost y pronto lo enviará para su aprobación a la Administración de Alimentos y ... Nicaragua Hoy

Lek na pogrubienie rzÄ™s  -  Dec 29, 2008
Substancja czynna leku, bimatoprost, została po raz pierwszy dopuszczona do użycia w 2001 roku. Wtedy jednak była stosowana do obniżenia ciśnienia w gałce ... KopalniaWiedzy

Glaucoma Drug Gets New Indication for Skimpy Eyelashes  -  Dec 30, 2008
30 -- The FDA has approved the glaucoma drug bimatoprost for treatment of ... Bimatoprost is not to be applied to the lower eyelid, the company said, ... MedPage Today

Long Beach Press-Telegram : U<br>  -  Jun 30, 2008
If bimatoprost is approved for eyelash growth, sales are expected to exceed ... Allergan would not comment on whether a bimatoprost-based lash formula could ... $3.50 - Press Telegram - NewsBank

Eyelash product ingredient focus of FDA seizure, Allergan lawsuit  -  Dec 2, 2007
A new version of the product (Age Intervention Eyelash Conditioner) does not contain bimatoprost and has not been embargoed, according to the statement, ... Ophthalmology Times

Article: Eyelash product containing glaucoma drug seized.(News)  -  Jan 1, 2008
The Food and Drug Administration seized more than 12000 tubes of a product claiming to increase eyelash growth because it was found to contain bimatoprost ... Pay-Per-View - Family Practice News - HighBeam Research

Hold the mascara; Drug has potential to grow thicker, longer lashes  -  Jun 30, 2008
One day soon you could have longer, thicker, darker eyelashes thanks to a drug called bimatoprost, which is now used to treat glaucoma and has a happy side- ... Pay-Per-View - The Spectator - ProQuest Archiver

LASHING OUT: HAIR GROWTH MAKERS STIR CONTROVERSY.  -  Feb 8, 2008
..."Bimatoprost is on a drug label. That technically shouldn't make a difference. ... "The original formula had bimatoprost in it. The current formula has a ... $9.94 - Women's Wear Daily - Alacra Store

Pfizer's Anti Glaucoma Eye Drop (Xalatan/Latanaprost) Continues to D ...  -  Apr 3, 2006
Latanoprost, Travoprost and Bimatoprost appear similarly effective for 24-hour IOP control: This double-masked, crossover study included 24 patients with ... Gerson Lehrman Group

The eye disease drug that gives you longer lashes  -  Oct 27, 2008
In a trial at Miami University, the drug, also known as bimatoprost, ... Those taking part were given two gels, one containing bimatoprost and the other a ... Daily Mail

Drug also cures lame lashes  -  Nov 6, 2008
In a trial at Miami University, the drug, also known as bimatoprost, ... Participants applied bimatoprost to one eye and a dummy drug to the other. ... Toronto Star

Lash-lengthening drug could soon replace mascara  -  Jun 23, 2008
One day soon you could have longer, thicker, darker eyelashes thanks to a drug called bimatoprost, which is now used to treat glaucoma and happens to have a ... Toronto Star

Cosmético que faz crescer cílios é aguardado por viciadas em rímel  -  Sep 21, 2008
Isso acontece porque, diz Mônica, o bimatoprost interage com o bulbo folicular (a raiz do ... “É o mesmo processo pelo qual está passando o bimatoprost. ... G1.com.br

Hyperemia in Glaucoma Patients  -  Jul 25, 2008
Abelson MB, Mroz M, Rosner SA, Dirks MS, Hirabayashi D. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with ... Medscape

EL TRATAMIENTO DEL GLAUCOMA CON LUMIGAN® PROPORCIONA …  -  May 5, 2008
El análisis de las reducciones de PIO sugiere que el cambio de latanoprost a bimatoprost va asociado a una posibilidad del 50% de alcanzar una reducción de ... acceso.com

Allergan Reports Second Quarter Operating Results; Total Product Net ...  -  Aug 2, 2006
A fixed combination of bimatoprost 0.03% and timolol maleate 0.5%, GANFORT(R) offers powerful IOP-lowering efficacy comparable to the free combination of ... $4.95 - Business Wire - ECNext

Glaucoma In-Depth Report  -  Sep 13, 2006
Latanoprost, travoprost, and bimatoprost need to be taken only once daily. ... Studies have suggested that bimatoprost is more effective in lowering eye ... New York Times

Getting started in therapeutics (C7947)  -  Nov 30, 2007
Bimatoprost (Lumigan) is a prostamide, a synthetic structural analogue of ... Bimatoprost is believed to lower IOP in humans by increasing outflow of ... Optician Online

Atlanta health, diet and fitness news | ajc.com  -  Nov 18, 2007
Specific problems in using Age Intervention Eyelash, the FDA said, were the patients already taking a prescription dose of bimatoprost may be in danger of ... Atlanta Journal Constitution

Glaukommedikament in Wimperntusche  -  Nov 19, 2007
Bimatoprost ist ein Prostaglandin-F2a-Analogon, das 2002 in Deutschland zur ... Bimatoprost verstärkt den Abfluss der Augenflüssigkeit im Kammerwinkel und ... Deutsches Ärzteblatt

FDA Confirms Seizure of Eyelash Product Was Not Prompted by Reports …  -  Nov 20, 2007
While Athena Cosmetics is confident that RevitaLash(R) is safe, because of possible public concern over bimatoprost created by the FDA's news release, ... $4.95 - PR Newswire - ECNext

Try a flutter with lash wonder creams  -  Aug 2, 2007
Dr Chesney says unlike bimatoprost, latanoprost rarely causes irritation. My tester of Age Intervention Eyelash (let's call her "Mum") says that after six ... Brisbane Times

Novo cosmético pode prejudicar a visão  -  Sep 24, 2008
...“Quanto menor for a concentração de bimatoprost neste cosmético, menores serão ... Queiroz Neto ressalta que se o bimatoprost penetrar na corrente sanguínea ... Agora MS

Le fabricant du Botox veut faire pousser les cils  -  Jun 8, 2008
Ce nouveau médicament, le Bimatoprost est une version synthétique de la ... Si elle obtient le feu vert de la FDA, le bimatoprost sera commercialisé aux USA ... Actualités medecine anti age

Novo Cosmético Pode Prejudicar a Visão  -  Oct 6, 2008
...“Quanto menor for a concentração de bimatoprost neste cosmético, menores serão ... Queiroz Neto ressalta que se o bimatoprost penetrar na corrente sanguínea ... Pravda.Ru

Netherlands Corporate News - Allergan krijgt pan-Europese vergunning ...  -  May 25, 2006
GANFORT®, een vaste combinatie van bimatoprost 0,03% en timololmaleaat 0,5%, biedt krachtige IOP-verlagende werkzaamheid die vergelijkbaar is met de vrije ... Netherlands Corporate News - Netherlands Corporate News (persbericht)

La Comisión Europea concede a Allergan licencia paneuropea para …  -  May 25, 2006
GANFORT(R), una combinación fija de bimatoprost al 0,03% y de maleato de timolol maleate al 0,5%, ofrece una gran eficacia en la reducción de PIO en ... elEconomista.es

FDA Approvals: Lumigan, Cesamet, Omnitrope  -  Jul 14, 2006
On June 22, the FDA approved an expanded indication for bimatoprost 0.03% ophthalmic solution ( Lumigan, made by Allergan, Inc), allowing its first-line use ... Medscape

Costs Rising to Make Intraocular Pressure Fall  -  Dec 28, 2007
Prostaglandin analogs ranged from $427.69 per year for travoprost (Travatan) in the 5.0 mL bottle size to $577.62 for bimatoprost in the 7.5 mL bottle size. ... MedPage Today

SpringfieldNewsSun: Dayton, Ohio, news and information  -  Dec 1, 2007
He was surprised the secret ingredient was bimatoprost, a close relative to ... Individuals using prescription bimatoprost could increase the risk of optic ... Springfield News Sun

Glaucoma Experts Determine That Reducing Intraocular Pressure …  -  May 11, 2007
A retrospective analysis of the Xalatan Lumigan Travatan (XLT) study show that three prostaglandins, latanoprost, bimatoprost and travoprost reduce the ... Medical News Today - Medical News Today (press release)

Comparison study: brimonidine fares well as add-on therapy: addition...  -  Jan 15, 2008
The primary therapy in the study eye was bimatoprost (Lumigan, Allergan; n = 71), latanoprost (Xalatan, Pfizer; n = 35), or travoprost (Travatan, Alcon; ... Free with registration - Ophthalmology Times - AccessMyLibrary.com

Contamination of Glaucoma Drugs Due to Patient Error More Than …  -  Apr 29, 2008
Bacteria were recovered from the tip or contents of 9% of BAK-containing prostaglandin agents (bimatoprost and travoprost) and from 8% of the BAK-free ... Medscape

Orange County Business Journal Online  -  Jun 30, 2008
In particular, he said the drug bimatoprost for longer eyelashes eventually ... Allergan filed a regulatory application for bimatoprost, which is an active ... Orange County Business Journal - Orange County Business Journal

Reducing ocular BAK exposure is optimal to eye health  -  May 15, 2007
In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells. ... OSN SuperSite

Timolol Fixed Combination Therapy Demonstrates Significantly Better...  -  Feb 6, 2008
...(1). Martinez A, Sanchez M. Bimatoprost/timolol fixed combination versus latanoprost/timolol fixed combination in open-angle glaucoma patients. presseportal.de

NO1.뉴미디어 마ì?´ë?°ì?¼ë¦¬  -  Oct 13, 2008
...� 연구� 따르면 복합제� '간�트'는 Bimatoprost 단�제� 비해 결막충혈� 40% 까지 낮췄고, non-fixed combination therapy (Bimatoprost+Timolol) 만� 안압강화 ... 마���리

Brži rast trepavica  -  Nov 12, 2008
Taj preparat se zove "bimatoprost", a predstavlja sintetiÄ?ku verziju hormona koji stimuliÅ¡e žlijezde koje se nalaze na korjenu svake trepavice. ... ГлаÑ? СрпÑ?ке

Press Release: MultiVu Video Feed: US Food and Drug Administration ( …  -  Dec 26, 2008
Administration (FDA) has approved LATISSE(TM) (bimatoprost ophthalmic solution ... inadequate or not enough eyelashes. LATISSE(TM) is the first and only ... Pay-Per-View - PR Newswire - HighBeam Research

Inflammatory syndrome tied to HIV Tx, mycobacterial coinfection.(Clini...  -  Jan 1, 2006
There was also one case of iris hyperpigmentation in a bimatoprost-treated patient; this is ... that bimatoprost-associated hyperpigmentation of the skin ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Press Release: New Study Demonstrates a Single Compound as …  -  May 3, 2006
Dr. Luca Rossetti, lead author of the study presented today, says "the fact that bimatoprost is effective in lowering IOP is not new to doctors treating ... Pay-Per-View - PR Newswire Europe - HighBeam Research

Article: Allergan seeks eyelash drug OK.(Policy & Practice) - Skin & ...  -  Jul 1, 2008
Allergan Inc. reported early last month that it is seeking Food and Drug Administration approval for its drug bimatoprost, to stimulate eyelash growth. ... Pay-Per-View - Skin & Allergy News - HighBeam Research

Press Release: FDA Confirms Seizure of Eyelash Product Was Not …  -  Nov 20, 2007
...bimatoprost, could possibly have deleterious side effects if it were ... eye with a medication used to treat glaucoma that also contains bimatoprost. ... Pay-Per-View - PR Newswire - HighBeam Research





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy